Comments on: About Ivan Oransky

By: Steven D Anisman MD FACC

Steven D Anisman MD FACC — Sat, 22 Sep 2012 21:29:38 +0000

Dr. Oransky,

I wanted to comment on not only the well-deserved prominent review in the NY Times, and on the excellent work you’re doing here, but also to comment on the obvious fact of your handsomeness and my strong suspicion that this is a family trait.

By: Colleen

Colleen — Tue, 23 Mar 2010 00:41:24 +0000

Ivan: My son attends NYU. Hope one day he is fortunate and savvy enough to enroll in one of your medical journalism courses. Enjoy following you on twitter. Thanks for the enlightening light you continue to shine. @ColleenAtRPCI.

By: ivanoransky

ivanoransky — Fri, 12 Mar 2010 03:06:58 +0000

Roxanne, thanks for reading and for the kind note. I look forward to your contributions.

Joe, great to have you keeping an eye on the blog, and I look forward to your contributions too. You raise an excellent point — it would be difficult for someone providing information to justify punishing someone who had never agreed to an embargo in the first place. An anecdote like that would be a great post, if anyone knows of one.

By: Joe Palca

Joe Palca — Thu, 11 Mar 2010 15:41:30 +0000

Ivan,
I’ve enjoyed reading through your blog. I’ve had a lot of experience with embargoes. I worked for Science and Nature before joining NPR, and I was on the advisory committee to Eurekalert when AAAS established its embargo policy. I will try to be energetic enough to contribute to the valuable discussion you’ve started.

The first point I’d like to raise is that an embargo is based on an agreement. It cannot be set unilaterally. Nature, NEJM, Eurekalert et. al. have asked me if I will agree to their embargo policies, and I have said yes. Had I said no, I wouldn’t be seeing their embargoed material.

But all too frequently, I get an “embargoed” news release from a person or journal I’ve never heard of. I feel very little obligation to observe that “embargo.” I didn’t ask for the material, and I made no commitment to observe some organization’s arbitrary rules.

More thoughts to come.

Joe

By: Roxanne Nelson

Roxanne Nelson — Tue, 09 Mar 2010 17:08:01 +0000

Cool blog, Ivan. Nice job. With all the embargo breaks recently, it’s nice to have all the info in one place. And as someone mentioned in the other comment, it would be interesting to hear the perspective of the organizations/journals whose embargoes have been broken.

By: Mary Jane Gore

Mary Jane Gore — Fri, 26 Feb 2010 14:14:17 +0000

Thanks, Ivan. Our office has been watching this issue of embargo breakage and wondering about the rest of the story, what happens to the reporters.

Looking forward to reading about the JAMA perspective.

Mary Jane
Duke Medicine News

By: ivanoransky

ivanoransky — Thu, 25 Feb 2010 15:58:29 +0000

I will take “horrible person” when it is this heartfelt and supportive! Thanks.

I have looked into one particular aspect of the link between embargoes and insider trading — the ASCO effect — and am gathering wool to post on that. Would love to hear about other examples and data.

By: Michael Kenward

Michael Kenward — Wed, 24 Feb 2010 22:39:52 +0000

You horrible person.

You have hit on an important subject that has exercised me so often over the years that I now have to follow this blog carefully.

Omigod, another Twit to follow too.

Well done. Seriously valuable thing to pursue.

Have you ever looked into the link between embargoes and insider trading?